Literature DB >> 21439655

Serum amyloid A3 (SAA3), not SAA1 appears to be the major acute phase SAA isoform in the pig.

L Soler1, T Luyten, A Stinckens, N Buys, J J Cerón, T A Niewold.   

Abstract

The acute-phase serum amyloid A (SAA) protein family comprises two main circulating (systemic) isoforms, SAA1 and SAA2, synthesised in liver and one local isoform, SAA3, produced in extrahepatic tissues. Systemic and local SAA show structural differences, which suggests different functions. In the pig, AA-amyloidosis is extremely uncommon, and the structural protein in swine has characteristics of systemic SAA. The only pig SAA sequences published so far, either derived form hepatic or extrahepatic sites have been designated SAA2, but the translated protein shows the properties of SAA3 proteins. The aim of this study was to characterise all the porcine SAA isoforms by sequencing from cDNA and genomic DNA obtained form multiple porcine tissues. Primer pairs were designed to amplify presumably all isoforms of SAA firstly and then specifically for each isotype. Results show that the only isotype isolated and sequenced both from hepatic and extrahepatic tissues correspond to a SAA3-like amino acid sequence. No SAA1-like sequences were identified, which could be indicative of the gene being very rare and consistent with the observed resistance to AA-amyloidosis. Finally, it is concluded that the pig is unique among other species in that the main circulating hepatic SAA isotype shows the characteristics of local highly alkaline SAA. This likely precludes a function as apolipoprotein.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439655     DOI: 10.1016/j.vetimm.2011.02.019

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  The Pig PeptideAtlas: A resource for systems biology in animal production and biomedicine.

Authors:  Marianne O Hesselager; Marius C Codrea; Zhi Sun; Eric W Deutsch; Tue B Bennike; Allan Stensballe; Louise Bundgaard; Robert L Moritz; Emøke Bendixen
Journal:  Proteomics       Date:  2016-02       Impact factor: 3.984

2.  Serum amyloid A and pairing formyl peptide receptor 2 are expressed in corneas and involved in inflammation-mediated neovascularization.

Authors:  Sheng-Wei Ren; Xia Qi; Chang-Kai Jia; Yi-Qiang Wang
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

Review 3.  Serum amyloid A1: Structure, function and gene polymorphism.

Authors:  Lei Sun; Richard D Ye
Journal:  Gene       Date:  2016-03-03       Impact factor: 3.688

Review 4.  Structure and Expression of Different Serum Amyloid A (SAA) Variants and their Concentration-Dependent Functions During Host Insults.

Authors:  Mieke De Buck; Mieke Gouwy; Ji Ming Wang; Jacques Van Snick; Ghislain Opdenakker; Sofie Struyf; Jo Van Damme
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

5.  Host-pathogen interplay at primary infection sites in pigs challenged with Actinobacillus pleuropneumoniae.

Authors:  Elena L Sassu; Janna Frömbling; J Catharina Duvigneau; Ingrid Miller; Andrea Müllebner; Ana M Gutiérrez; Tom Grunert; Martina Patzl; Armin Saalmüller; Alexandra von Altrock; Anne Menzel; Martin Ganter; Joachim Spergser; Marion Hewicker-Trautwein; Jutta Verspohl; Monika Ehling-Schulz; Isabel Hennig-Pauka
Journal:  BMC Vet Res       Date:  2017-02-28       Impact factor: 2.741

6.  Comprehensive transcriptome profiling of urothelial cells following TNFα stimulation in an in vitro interstitial cystitis/bladder pain syndrome model.

Authors:  Tadeja Kuret; Dominika Peskar; Mateja Erdani Kreft; Andreja Erman; Peter Veranič
Journal:  Front Immunol       Date:  2022-08-15       Impact factor: 8.786

7.  Organization and biology of the porcine serum amyloid A (SAA) gene cluster: isoform specific responses to bacterial infection.

Authors:  Helle G Olsen; Kerstin Skovgaard; Ole L Nielsen; Páll S Leifsson; Henrik E Jensen; Tine Iburg; Peter M H Heegaard
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.